Drug Type Small molecule drug  | 
Synonyms PH-009, PH009, PH009 1 + [1]  | 
Action inhibitors  | 
Mechanism EGFR C797S inhibitors(Epidermal Growth Factor Receptor C797S inhibitors), EGFR T790M inhibitors(Epidermal Growth Factor Receptor T790M inhibitors), EGFR exon 19 deletion inhibitors  | 
Therapeutic Areas  | 
Inactive Indication-  | 
Originator Organization  | 
Active Organization  | 
Inactive Organization-  | 
License Organization-  | 
Drug Highest PhasePhase 1/2  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| EGFR-mutated non-small Cell Lung Cancer | Phase 2 | China   | 10 Sep 2024 | |
| EGFR T790M Mutation Positive Non-Small Cell Lung Carcinoma | Preclinical | China   | 17 Apr 2023 | 





